
    
      Bendamustine will be started in the first group at a dose of 60 mg/m²; patients in group 2
      will be given Bendamustine at a dose of 80 mg/m²; patients in Group 3 will be given
      Bendamustine at 100 mg/m². Each cohort will receive Bendamustine once weekly for a total of 4
      weeks.

      Approximately 3-6 patients enrolled in this study will receive lumbar punctures. Patients
      will be told before study enrollment whether they will have a lumbar puncture to withdraw
      CSF.
    
  